nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—GNRHR—gonad—ovarian cancer	0.00529	0.292	CbGeAlD
Nafarelin—GNRHR—female reproductive system—ovarian cancer	0.00472	0.261	CbGeAlD
Nafarelin—GNRHR—female gonad—ovarian cancer	0.0043	0.237	CbGeAlD
Nafarelin—GNRHR—testis—ovarian cancer	0.00381	0.21	CbGeAlD
Nafarelin—Dysuria—Paclitaxel—ovarian cancer	0.00187	0.0019	CcSEcCtD
Nafarelin—Vertigo—Vinorelbine—ovarian cancer	0.00186	0.00189	CcSEcCtD
Nafarelin—Coordination abnormal—Epirubicin—ovarian cancer	0.00185	0.00189	CcSEcCtD
Nafarelin—Anorexia—Melphalan—ovarian cancer	0.00184	0.00188	CcSEcCtD
Nafarelin—Palpitations—Vinorelbine—ovarian cancer	0.00183	0.00186	CcSEcCtD
Nafarelin—Oliguria—Doxorubicin—ovarian cancer	0.00183	0.00186	CcSEcCtD
Nafarelin—Herpes simplex—Doxorubicin—ovarian cancer	0.00183	0.00186	CcSEcCtD
Nafarelin—Pulmonary embolism—Epirubicin—ovarian cancer	0.00182	0.00185	CcSEcCtD
Nafarelin—Weight increased—Paclitaxel—ovarian cancer	0.00182	0.00185	CcSEcCtD
Nafarelin—Weight decreased—Paclitaxel—ovarian cancer	0.00181	0.00184	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.0018	0.00183	CcSEcCtD
Nafarelin—Dry skin—Docetaxel—ovarian cancer	0.00179	0.00183	CcSEcCtD
Nafarelin—Cystitis noninfective—Epirubicin—ovarian cancer	0.00178	0.00181	CcSEcCtD
Nafarelin—Depression—Paclitaxel—ovarian cancer	0.00177	0.00181	CcSEcCtD
Nafarelin—Paraesthesia—Topotecan—ovarian cancer	0.00177	0.0018	CcSEcCtD
Nafarelin—Urticaria—Chlorambucil—ovarian cancer	0.00176	0.00179	CcSEcCtD
Nafarelin—Chest pain—Vinorelbine—ovarian cancer	0.00176	0.00179	CcSEcCtD
Nafarelin—Arthralgia—Vinorelbine—ovarian cancer	0.00176	0.00179	CcSEcCtD
Nafarelin—Myalgia—Vinorelbine—ovarian cancer	0.00176	0.00179	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00176	0.00179	CcSEcCtD
Nafarelin—Dyspnoea—Topotecan—ovarian cancer	0.00176	0.00179	CcSEcCtD
Nafarelin—Cystitis—Epirubicin—ovarian cancer	0.00176	0.00179	CcSEcCtD
Nafarelin—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.00175	0.00179	CcSEcCtD
Nafarelin—Myocardial infarction—Paclitaxel—ovarian cancer	0.00174	0.00178	CcSEcCtD
Nafarelin—Paraesthesia—Melphalan—ovarian cancer	0.00173	0.00177	CcSEcCtD
Nafarelin—Conjunctivitis—Paclitaxel—ovarian cancer	0.00173	0.00176	CcSEcCtD
Nafarelin—Dyspnoea—Melphalan—ovarian cancer	0.00172	0.00175	CcSEcCtD
Nafarelin—Decreased appetite—Topotecan—ovarian cancer	0.00171	0.00175	CcSEcCtD
Nafarelin—Coordination abnormal—Doxorubicin—ovarian cancer	0.00171	0.00175	CcSEcCtD
Nafarelin—Constipation—Topotecan—ovarian cancer	0.00169	0.00172	CcSEcCtD
Nafarelin—Pulmonary embolism—Doxorubicin—ovarian cancer	0.00168	0.00171	CcSEcCtD
Nafarelin—Decreased appetite—Melphalan—ovarian cancer	0.00168	0.00171	CcSEcCtD
Nafarelin—Epistaxis—Paclitaxel—ovarian cancer	0.00168	0.00171	CcSEcCtD
Nafarelin—Sinusitis—Paclitaxel—ovarian cancer	0.00167	0.0017	CcSEcCtD
Nafarelin—Rash maculo-papular—Epirubicin—ovarian cancer	0.00165	0.00168	CcSEcCtD
Nafarelin—Bladder pain—Epirubicin—ovarian cancer	0.00164	0.00167	CcSEcCtD
Nafarelin—Neoplasm—Epirubicin—ovarian cancer	0.00164	0.00167	CcSEcCtD
Nafarelin—Cystitis noninfective—Doxorubicin—ovarian cancer	0.00164	0.00167	CcSEcCtD
Nafarelin—Cystitis—Doxorubicin—ovarian cancer	0.00163	0.00166	CcSEcCtD
Nafarelin—Anorexia—Vinorelbine—ovarian cancer	0.00161	0.00164	CcSEcCtD
Nafarelin—Rhinitis—Paclitaxel—ovarian cancer	0.0016	0.00163	CcSEcCtD
Nafarelin—Asthenia—Chlorambucil—ovarian cancer	0.00159	0.00162	CcSEcCtD
Nafarelin—Pruritus—Chlorambucil—ovarian cancer	0.00157	0.0016	CcSEcCtD
Nafarelin—Urticaria—Topotecan—ovarian cancer	0.00157	0.0016	CcSEcCtD
Nafarelin—Weight increased—Docetaxel—ovarian cancer	0.00154	0.00157	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00154	0.00157	CcSEcCtD
Nafarelin—Urticaria—Melphalan—ovarian cancer	0.00153	0.00156	CcSEcCtD
Nafarelin—Weight decreased—Docetaxel—ovarian cancer	0.00153	0.00156	CcSEcCtD
Nafarelin—Rash maculo-papular—Doxorubicin—ovarian cancer	0.00153	0.00156	CcSEcCtD
Nafarelin—Neoplasm—Doxorubicin—ovarian cancer	0.00152	0.00155	CcSEcCtD
Nafarelin—Bladder pain—Doxorubicin—ovarian cancer	0.00152	0.00155	CcSEcCtD
Nafarelin—Diarrhoea—Chlorambucil—ovarian cancer	0.00152	0.00154	CcSEcCtD
Nafarelin—Paraesthesia—Vinorelbine—ovarian cancer	0.00152	0.00154	CcSEcCtD
Nafarelin—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00151	0.00154	CcSEcCtD
Nafarelin—Dyspnoea—Vinorelbine—ovarian cancer	0.0015	0.00153	CcSEcCtD
Nafarelin—Acute coronary syndrome—Docetaxel—ovarian cancer	0.00149	0.00151	CcSEcCtD
Nafarelin—Myocardial infarction—Docetaxel—ovarian cancer	0.00148	0.00151	CcSEcCtD
Nafarelin—Decreased appetite—Vinorelbine—ovarian cancer	0.00147	0.00149	CcSEcCtD
Nafarelin—Conjunctivitis—Docetaxel—ovarian cancer	0.00147	0.00149	CcSEcCtD
Nafarelin—Eye pain—Epirubicin—ovarian cancer	0.00146	0.00149	CcSEcCtD
Nafarelin—Constipation—Vinorelbine—ovarian cancer	0.00144	0.00147	CcSEcCtD
Nafarelin—Epistaxis—Docetaxel—ovarian cancer	0.00142	0.00145	CcSEcCtD
Nafarelin—Asthenia—Topotecan—ovarian cancer	0.00142	0.00144	CcSEcCtD
Nafarelin—Alopecia—Paclitaxel—ovarian cancer	0.00141	0.00144	CcSEcCtD
Nafarelin—Hot flush—Epirubicin—ovarian cancer	0.00141	0.00144	CcSEcCtD
Nafarelin—Vomiting—Chlorambucil—ovarian cancer	0.00141	0.00144	CcSEcCtD
Nafarelin—Increased appetite—Epirubicin—ovarian cancer	0.00141	0.00143	CcSEcCtD
Nafarelin—Mental disorder—Paclitaxel—ovarian cancer	0.0014	0.00143	CcSEcCtD
Nafarelin—Menopausal symptoms—Epirubicin—ovarian cancer	0.0014	0.00143	CcSEcCtD
Nafarelin—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.0014	0.00142	CcSEcCtD
Nafarelin—Pruritus—Topotecan—ovarian cancer	0.0014	0.00142	CcSEcCtD
Nafarelin—Malnutrition—Paclitaxel—ovarian cancer	0.00139	0.00142	CcSEcCtD
Nafarelin—Asthenia—Melphalan—ovarian cancer	0.00139	0.00141	CcSEcCtD
Nafarelin—Pruritus—Melphalan—ovarian cancer	0.00137	0.00139	CcSEcCtD
Nafarelin—Tension—Paclitaxel—ovarian cancer	0.00136	0.00139	CcSEcCtD
Nafarelin—Dysgeusia—Paclitaxel—ovarian cancer	0.00136	0.00139	CcSEcCtD
Nafarelin—Rhinitis—Docetaxel—ovarian cancer	0.00136	0.00138	CcSEcCtD
Nafarelin—Eye pain—Doxorubicin—ovarian cancer	0.00135	0.00138	CcSEcCtD
Nafarelin—Nervousness—Paclitaxel—ovarian cancer	0.00135	0.00138	CcSEcCtD
Nafarelin—Diarrhoea—Topotecan—ovarian cancer	0.00135	0.00137	CcSEcCtD
Nafarelin—Cerebrovascular accident—Epirubicin—ovarian cancer	0.00135	0.00137	CcSEcCtD
Nafarelin—Urticaria—Vinorelbine—ovarian cancer	0.00134	0.00137	CcSEcCtD
Nafarelin—Diarrhoea—Melphalan—ovarian cancer	0.00132	0.00135	CcSEcCtD
Nafarelin—Nausea—Chlorambucil—ovarian cancer	0.00132	0.00134	CcSEcCtD
Nafarelin—Hot flush—Doxorubicin—ovarian cancer	0.00131	0.00133	CcSEcCtD
Nafarelin—Dizziness—Topotecan—ovarian cancer	0.0013	0.00133	CcSEcCtD
Nafarelin—Increased appetite—Doxorubicin—ovarian cancer	0.0013	0.00132	CcSEcCtD
Nafarelin—Affect lability—Epirubicin—ovarian cancer	0.0013	0.00132	CcSEcCtD
Nafarelin—Menopausal symptoms—Doxorubicin—ovarian cancer	0.00129	0.00132	CcSEcCtD
Nafarelin—Vomiting—Topotecan—ovarian cancer	0.00125	0.00128	CcSEcCtD
Nafarelin—Mood swings—Epirubicin—ovarian cancer	0.00125	0.00127	CcSEcCtD
Nafarelin—Vertigo—Paclitaxel—ovarian cancer	0.00125	0.00127	CcSEcCtD
Nafarelin—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.00125	0.00127	CcSEcCtD
Nafarelin—Rash—Topotecan—ovarian cancer	0.00124	0.00127	CcSEcCtD
Nafarelin—Dermatitis—Topotecan—ovarian cancer	0.00124	0.00127	CcSEcCtD
Nafarelin—Headache—Topotecan—ovarian cancer	0.00124	0.00126	CcSEcCtD
Nafarelin—Palpitations—Paclitaxel—ovarian cancer	0.00123	0.00125	CcSEcCtD
Nafarelin—Vomiting—Melphalan—ovarian cancer	0.00123	0.00125	CcSEcCtD
Nafarelin—Rash—Melphalan—ovarian cancer	0.00122	0.00124	CcSEcCtD
Nafarelin—Dermatitis—Melphalan—ovarian cancer	0.00122	0.00124	CcSEcCtD
Nafarelin—Asthenia—Vinorelbine—ovarian cancer	0.00121	0.00123	CcSEcCtD
Nafarelin—Dry skin—Epirubicin—ovarian cancer	0.00121	0.00123	CcSEcCtD
Nafarelin—Convulsion—Paclitaxel—ovarian cancer	0.00121	0.00123	CcSEcCtD
Nafarelin—Affect lability—Doxorubicin—ovarian cancer	0.0012	0.00122	CcSEcCtD
Nafarelin—Alopecia—Docetaxel—ovarian cancer	0.0012	0.00122	CcSEcCtD
Nafarelin—Pruritus—Vinorelbine—ovarian cancer	0.00119	0.00122	CcSEcCtD
Nafarelin—Mental disorder—Docetaxel—ovarian cancer	0.00119	0.00121	CcSEcCtD
Nafarelin—Arthralgia—Paclitaxel—ovarian cancer	0.00118	0.00121	CcSEcCtD
Nafarelin—Chest pain—Paclitaxel—ovarian cancer	0.00118	0.00121	CcSEcCtD
Nafarelin—Myalgia—Paclitaxel—ovarian cancer	0.00118	0.00121	CcSEcCtD
Nafarelin—Malnutrition—Docetaxel—ovarian cancer	0.00118	0.0012	CcSEcCtD
Nafarelin—Nausea—Topotecan—ovarian cancer	0.00117	0.00119	CcSEcCtD
Nafarelin—Gastritis—Epirubicin—ovarian cancer	0.00117	0.00119	CcSEcCtD
Nafarelin—Muscular weakness—Epirubicin—ovarian cancer	0.00116	0.00119	CcSEcCtD
Nafarelin—Mood swings—Doxorubicin—ovarian cancer	0.00116	0.00118	CcSEcCtD
Nafarelin—Diarrhoea—Vinorelbine—ovarian cancer	0.00115	0.00118	CcSEcCtD
Nafarelin—Dysgeusia—Docetaxel—ovarian cancer	0.00115	0.00118	CcSEcCtD
Nafarelin—Abdominal distension—Epirubicin—ovarian cancer	0.00115	0.00117	CcSEcCtD
Nafarelin—Nausea—Melphalan—ovarian cancer	0.00115	0.00117	CcSEcCtD
Nafarelin—Oedema—Paclitaxel—ovarian cancer	0.00114	0.00116	CcSEcCtD
Nafarelin—Dry skin—Doxorubicin—ovarian cancer	0.00112	0.00114	CcSEcCtD
Nafarelin—Shock—Paclitaxel—ovarian cancer	0.00112	0.00114	CcSEcCtD
Nafarelin—Dizziness—Vinorelbine—ovarian cancer	0.00112	0.00114	CcSEcCtD
Nafarelin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.0011	0.00112	CcSEcCtD
Nafarelin—Anorexia—Paclitaxel—ovarian cancer	0.00108	0.0011	CcSEcCtD
Nafarelin—Gastritis—Doxorubicin—ovarian cancer	0.00108	0.0011	CcSEcCtD
Nafarelin—Muscular weakness—Doxorubicin—ovarian cancer	0.00108	0.0011	CcSEcCtD
Nafarelin—Vomiting—Vinorelbine—ovarian cancer	0.00107	0.00109	CcSEcCtD
Nafarelin—Dysuria—Epirubicin—ovarian cancer	0.00107	0.00109	CcSEcCtD
Nafarelin—Rash—Vinorelbine—ovarian cancer	0.00106	0.00108	CcSEcCtD
Nafarelin—Dermatitis—Vinorelbine—ovarian cancer	0.00106	0.00108	CcSEcCtD
Nafarelin—Abdominal distension—Doxorubicin—ovarian cancer	0.00106	0.00108	CcSEcCtD
Nafarelin—Headache—Vinorelbine—ovarian cancer	0.00106	0.00108	CcSEcCtD
Nafarelin—Palpitations—Docetaxel—ovarian cancer	0.00104	0.00106	CcSEcCtD
Nafarelin—Weight increased—Epirubicin—ovarian cancer	0.00104	0.00106	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00103	0.00105	CcSEcCtD
Nafarelin—Weight decreased—Epirubicin—ovarian cancer	0.00103	0.00105	CcSEcCtD
Nafarelin—Insomnia—Paclitaxel—ovarian cancer	0.00103	0.00105	CcSEcCtD
Nafarelin—Convulsion—Docetaxel—ovarian cancer	0.00102	0.00104	CcSEcCtD
Nafarelin—Paraesthesia—Paclitaxel—ovarian cancer	0.00102	0.00104	CcSEcCtD
Nafarelin—Dyspnoea—Paclitaxel—ovarian cancer	0.00101	0.00103	CcSEcCtD
Nafarelin—Arthralgia—Docetaxel—ovarian cancer	0.001	0.00102	CcSEcCtD
Nafarelin—Chest pain—Docetaxel—ovarian cancer	0.001	0.00102	CcSEcCtD
Nafarelin—Myalgia—Docetaxel—ovarian cancer	0.001	0.00102	CcSEcCtD
Nafarelin—Nausea—Vinorelbine—ovarian cancer	0.001	0.00102	CcSEcCtD
Nafarelin—Conjunctivitis—Epirubicin—ovarian cancer	0.000989	0.00101	CcSEcCtD
Nafarelin—Dysuria—Doxorubicin—ovarian cancer	0.000987	0.00101	CcSEcCtD
Nafarelin—Decreased appetite—Paclitaxel—ovarian cancer	0.000987	0.00101	CcSEcCtD
Nafarelin—Constipation—Paclitaxel—ovarian cancer	0.000971	0.000989	CcSEcCtD
Nafarelin—Oedema—Docetaxel—ovarian cancer	0.000962	0.00098	CcSEcCtD
Nafarelin—Weight increased—Doxorubicin—ovarian cancer	0.000961	0.000979	CcSEcCtD
Nafarelin—Epistaxis—Epirubicin—ovarian cancer	0.00096	0.000977	CcSEcCtD
Nafarelin—Weight decreased—Doxorubicin—ovarian cancer	0.000955	0.000973	CcSEcCtD
Nafarelin—Sinusitis—Epirubicin—ovarian cancer	0.000955	0.000972	CcSEcCtD
Nafarelin—Shock—Docetaxel—ovarian cancer	0.000947	0.000964	CcSEcCtD
Nafarelin—Anorexia—Docetaxel—ovarian cancer	0.000917	0.000934	CcSEcCtD
Nafarelin—Rhinitis—Epirubicin—ovarian cancer	0.000916	0.000933	CcSEcCtD
Nafarelin—Conjunctivitis—Doxorubicin—ovarian cancer	0.000915	0.000932	CcSEcCtD
Nafarelin—Urticaria—Paclitaxel—ovarian cancer	0.000902	0.000918	CcSEcCtD
Nafarelin—Epistaxis—Doxorubicin—ovarian cancer	0.000888	0.000904	CcSEcCtD
Nafarelin—Sinusitis—Doxorubicin—ovarian cancer	0.000883	0.0009	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000877	0.000893	CcSEcCtD
Nafarelin—Insomnia—Docetaxel—ovarian cancer	0.00087	0.000886	CcSEcCtD
Nafarelin—Paraesthesia—Docetaxel—ovarian cancer	0.000864	0.00088	CcSEcCtD
Nafarelin—Dyspnoea—Docetaxel—ovarian cancer	0.000858	0.000874	CcSEcCtD
Nafarelin—Rhinitis—Doxorubicin—ovarian cancer	0.000847	0.000863	CcSEcCtD
Nafarelin—Decreased appetite—Docetaxel—ovarian cancer	0.000836	0.000852	CcSEcCtD
Nafarelin—Constipation—Docetaxel—ovarian cancer	0.000823	0.000838	CcSEcCtD
Nafarelin—Asthenia—Paclitaxel—ovarian cancer	0.000814	0.000829	CcSEcCtD
Nafarelin—Alopecia—Epirubicin—ovarian cancer	0.000807	0.000822	CcSEcCtD
Nafarelin—Pruritus—Paclitaxel—ovarian cancer	0.000803	0.000818	CcSEcCtD
Nafarelin—Mental disorder—Epirubicin—ovarian cancer	0.0008	0.000815	CcSEcCtD
Nafarelin—Malnutrition—Epirubicin—ovarian cancer	0.000795	0.00081	CcSEcCtD
Nafarelin—Tension—Epirubicin—ovarian cancer	0.00078	0.000795	CcSEcCtD
Nafarelin—Dysgeusia—Epirubicin—ovarian cancer	0.000779	0.000793	CcSEcCtD
Nafarelin—Diarrhoea—Paclitaxel—ovarian cancer	0.000777	0.000791	CcSEcCtD
Nafarelin—Nervousness—Epirubicin—ovarian cancer	0.000772	0.000787	CcSEcCtD
Nafarelin—Dizziness—Paclitaxel—ovarian cancer	0.000751	0.000765	CcSEcCtD
Nafarelin—Alopecia—Doxorubicin—ovarian cancer	0.000747	0.000761	CcSEcCtD
Nafarelin—Mental disorder—Doxorubicin—ovarian cancer	0.00074	0.000754	CcSEcCtD
Nafarelin—Malnutrition—Doxorubicin—ovarian cancer	0.000736	0.000749	CcSEcCtD
Nafarelin—Tension—Doxorubicin—ovarian cancer	0.000722	0.000735	CcSEcCtD
Nafarelin—Vomiting—Paclitaxel—ovarian cancer	0.000722	0.000735	CcSEcCtD
Nafarelin—Dysgeusia—Doxorubicin—ovarian cancer	0.000721	0.000734	CcSEcCtD
Nafarelin—Rash—Paclitaxel—ovarian cancer	0.000716	0.000729	CcSEcCtD
Nafarelin—Dermatitis—Paclitaxel—ovarian cancer	0.000715	0.000728	CcSEcCtD
Nafarelin—Nervousness—Doxorubicin—ovarian cancer	0.000715	0.000728	CcSEcCtD
Nafarelin—Vertigo—Epirubicin—ovarian cancer	0.000714	0.000728	CcSEcCtD
Nafarelin—Headache—Paclitaxel—ovarian cancer	0.000711	0.000724	CcSEcCtD
Nafarelin—Palpitations—Epirubicin—ovarian cancer	0.000703	0.000716	CcSEcCtD
Nafarelin—Asthenia—Docetaxel—ovarian cancer	0.00069	0.000703	CcSEcCtD
Nafarelin—Convulsion—Epirubicin—ovarian cancer	0.000689	0.000702	CcSEcCtD
Nafarelin—Pruritus—Docetaxel—ovarian cancer	0.000681	0.000693	CcSEcCtD
Nafarelin—Chest pain—Epirubicin—ovarian cancer	0.000677	0.000689	CcSEcCtD
Nafarelin—Arthralgia—Epirubicin—ovarian cancer	0.000677	0.000689	CcSEcCtD
Nafarelin—Myalgia—Epirubicin—ovarian cancer	0.000677	0.000689	CcSEcCtD
Nafarelin—Nausea—Paclitaxel—ovarian cancer	0.000674	0.000687	CcSEcCtD
Nafarelin—Vertigo—Doxorubicin—ovarian cancer	0.000661	0.000673	CcSEcCtD
Nafarelin—Diarrhoea—Docetaxel—ovarian cancer	0.000658	0.00067	CcSEcCtD
Nafarelin—Palpitations—Doxorubicin—ovarian cancer	0.00065	0.000662	CcSEcCtD
Nafarelin—Oedema—Epirubicin—ovarian cancer	0.000649	0.000661	CcSEcCtD
Nafarelin—Shock—Epirubicin—ovarian cancer	0.000638	0.00065	CcSEcCtD
Nafarelin—Convulsion—Doxorubicin—ovarian cancer	0.000637	0.000649	CcSEcCtD
Nafarelin—Dizziness—Docetaxel—ovarian cancer	0.000636	0.000648	CcSEcCtD
Nafarelin—Hyperhidrosis—Epirubicin—ovarian cancer	0.000627	0.000639	CcSEcCtD
Nafarelin—Chest pain—Doxorubicin—ovarian cancer	0.000626	0.000638	CcSEcCtD
Nafarelin—Arthralgia—Doxorubicin—ovarian cancer	0.000626	0.000638	CcSEcCtD
Nafarelin—Myalgia—Doxorubicin—ovarian cancer	0.000626	0.000638	CcSEcCtD
Nafarelin—Anorexia—Epirubicin—ovarian cancer	0.000619	0.00063	CcSEcCtD
Nafarelin—Vomiting—Docetaxel—ovarian cancer	0.000612	0.000623	CcSEcCtD
Nafarelin—Rash—Docetaxel—ovarian cancer	0.000607	0.000618	CcSEcCtD
Nafarelin—Dermatitis—Docetaxel—ovarian cancer	0.000606	0.000617	CcSEcCtD
Nafarelin—Headache—Docetaxel—ovarian cancer	0.000603	0.000614	CcSEcCtD
Nafarelin—Oedema—Doxorubicin—ovarian cancer	0.0006	0.000612	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000591	0.000602	CcSEcCtD
Nafarelin—Shock—Doxorubicin—ovarian cancer	0.000591	0.000602	CcSEcCtD
Nafarelin—Insomnia—Epirubicin—ovarian cancer	0.000587	0.000598	CcSEcCtD
Nafarelin—Paraesthesia—Epirubicin—ovarian cancer	0.000583	0.000594	CcSEcCtD
Nafarelin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000581	0.000591	CcSEcCtD
Nafarelin—Dyspnoea—Epirubicin—ovarian cancer	0.000579	0.000589	CcSEcCtD
Nafarelin—Anorexia—Doxorubicin—ovarian cancer	0.000572	0.000583	CcSEcCtD
Nafarelin—Nausea—Docetaxel—ovarian cancer	0.000572	0.000582	CcSEcCtD
Nafarelin—Decreased appetite—Epirubicin—ovarian cancer	0.000564	0.000575	CcSEcCtD
Nafarelin—Constipation—Epirubicin—ovarian cancer	0.000555	0.000565	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000547	0.000557	CcSEcCtD
Nafarelin—Insomnia—Doxorubicin—ovarian cancer	0.000543	0.000553	CcSEcCtD
Nafarelin—Paraesthesia—Doxorubicin—ovarian cancer	0.000539	0.000549	CcSEcCtD
Nafarelin—Dyspnoea—Doxorubicin—ovarian cancer	0.000535	0.000545	CcSEcCtD
Nafarelin—Decreased appetite—Doxorubicin—ovarian cancer	0.000522	0.000532	CcSEcCtD
Nafarelin—Urticaria—Epirubicin—ovarian cancer	0.000516	0.000525	CcSEcCtD
Nafarelin—Constipation—Doxorubicin—ovarian cancer	0.000513	0.000523	CcSEcCtD
Nafarelin—Urticaria—Doxorubicin—ovarian cancer	0.000477	0.000486	CcSEcCtD
Nafarelin—Asthenia—Epirubicin—ovarian cancer	0.000466	0.000474	CcSEcCtD
Nafarelin—Pruritus—Epirubicin—ovarian cancer	0.000459	0.000468	CcSEcCtD
Nafarelin—Diarrhoea—Epirubicin—ovarian cancer	0.000444	0.000452	CcSEcCtD
Nafarelin—Asthenia—Doxorubicin—ovarian cancer	0.000431	0.000439	CcSEcCtD
Nafarelin—Dizziness—Epirubicin—ovarian cancer	0.000429	0.000437	CcSEcCtD
Nafarelin—Pruritus—Doxorubicin—ovarian cancer	0.000425	0.000433	CcSEcCtD
Nafarelin—Vomiting—Epirubicin—ovarian cancer	0.000413	0.00042	CcSEcCtD
Nafarelin—Diarrhoea—Doxorubicin—ovarian cancer	0.000411	0.000418	CcSEcCtD
Nafarelin—Rash—Epirubicin—ovarian cancer	0.000409	0.000417	CcSEcCtD
Nafarelin—Dermatitis—Epirubicin—ovarian cancer	0.000409	0.000416	CcSEcCtD
Nafarelin—Headache—Epirubicin—ovarian cancer	0.000407	0.000414	CcSEcCtD
Nafarelin—Dizziness—Doxorubicin—ovarian cancer	0.000397	0.000404	CcSEcCtD
Nafarelin—Nausea—Epirubicin—ovarian cancer	0.000385	0.000393	CcSEcCtD
Nafarelin—Vomiting—Doxorubicin—ovarian cancer	0.000382	0.000389	CcSEcCtD
Nafarelin—Rash—Doxorubicin—ovarian cancer	0.000379	0.000386	CcSEcCtD
Nafarelin—Dermatitis—Doxorubicin—ovarian cancer	0.000378	0.000385	CcSEcCtD
Nafarelin—Headache—Doxorubicin—ovarian cancer	0.000376	0.000383	CcSEcCtD
Nafarelin—Nausea—Doxorubicin—ovarian cancer	0.000357	0.000363	CcSEcCtD
